Imalek Tablets (matinib mesylate) belongs to the group of medicines called Tyrosine Kinase Inhibitors. Its active ingredient is matinib mesylate used in the treatment of blood cancer (chronic myeloid leukemia and Acute lymphocytic leukemia) and gastrointestinal stromal tumor.
read more..